US Retina Market Quarterly Updates
|出版商||Market Scope, LLC||商品編碼||644709|
|美國的視網膜治療市場:季報 US Retina Market Quarterly Updates|
|出版日期: 4 Issues/Year||內容資訊: 英文||
本報告提供美國的視網膜治療市場上主要標準相關分析，治療藥 (Lucentis，Eylea，Avastin)的使用，IVT (玻璃體內注射) 注射，DME (糖尿病黃斑部水腫)的治療，皮質類固醇的使用，光凝固手術數量和光凝固設備的使用，玻璃體切除數量和定位，拋棄式手術用套件等相關彙整。
Our US Retinal Market Quarterly Updates are designed to keep you up to date with data gathered four times per year on the practice of retinal medicine, both pharmaceutical and surgical. We began this survey process in 2008. These updates are designed to improve your decision-making process with accurate and timely information on a variety of vital practice of medicine issues, doctors' evaluations of pharmaceuticals and surgical equipment, and the identification of significant trends in the marketplace for retinal pharmaceuticals and devices.
Our updates include trend analysis based on comparisons with information gathered in previous years. All information is presented in color charts and tables with concise narratives for enhanced clarity and context.
We measure and analyze the key metrics of the US retina treatments market, including the following topics:
We also provide a full-year forecast for US retinal procedures (including IVT injections) and a comparison with volumes during the prior year. The survey has been developed in conjunction with retina specialists and industry manufacturers.
Our US Retina Quarterly Market Updates are published each quarter. We have been conducting surveys of ophthalmologists in various subspecialties for 12 years, and our analyses of survey data are used by hundreds of ophthalmological practices and businesses in the ophthalmic industry. Each update can be purchased separately for $3,000, or an annual subscription is available for $10,750.
*Note: The PDFs are not downloadable: PDF copies of reports are manually prepared and emailed to the account listed on the order within 24 hours.